Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (102971)	6/19/2000 5:21:00 PM
From: kha vu	Respond to of 120523

Hi Jenna, In your last analysis MRVC is now hitting the resistance at 60+. Would you please check it technically. As of the good market and the plentiful money on the sideline could help MRVC breakout this resistance. ??? thanks kha

To: Jenna who wrote (102971)	6/19/2000 7:55:00 PM
From: DlphcOracl	Read Replies (1) \| Respond to of 120523

Jenna and thread: Any thought on PEB? While most of the biotech favorites have nearly doubled since the April NASDAQ low, PEB has not participated and is nearly flat. It is the "picks-and shovels" play in the genomics sector, is profitable, and looks cheap on a valuation basis. Is there a good reason to avoid this stock (dead money) or is this an overlooked gem? Any thoughts would be appreciated. Disclosure: I do not own nor am I short PEB, but am considering it for LT buy.